The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
MG‐ADL: Still a relevant outcome measure
Abstract
Introduction: The aim of this analysis was to examine the performance of the Myasthenia Gravis–specific Activities of Daily Living scale (MG‐ADL) during a multicenter scale validation study. Methods: Consecutive MG patients were assessed with several MG outcome measures, including the MG‐ADL. Statistical tests included descriptive analysis, Pearson correlation, and sensitivity/specificity. Results: Eighty‐seven patients completed the MG‐ADL, MG Composite (MGC), and MG 15‐item Quality of Life scale (MG‐QOL15) on the first visit, and 76 returned for the second visit. At the first visit, there was a strong positive correlation between MG‐ADL and MGC (r = 0.85, P < 0.0001) and MG‐QOL15 (r = 0.76, P < 0.0001). Correlation of the delta MG‐ADL score and physician impression of change between the visits was strong (r = 0.70, P < 0.0001). A 2‐point improvement in the MG‐ADL best predicted clinical improvement. Test–retest analysis demonstrated a high reliability coefficient. Conclusions: The MG‐ADL correlates strongly with newer, validated MG outcome measures. A 2‐point improvement in the MG‐ADL indicates clinical improvement. The MG‐ADL is useful as a research tool and in routine clinical management. Muscle Nerve, 2011
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lifetime course of myasthenia gravis
Grob, D., Brunner, N., Namba, T., & Pagala, M. (2008) · Muscle & Nerve · doi:10.1002/mus.20950 · Cited by 733
Cited by
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
Howard, J. F., Bril, V., Burns, T. M., Mantegazza, R., Bilinska, M., Szczudlik, A., Beydoun, S., Garrido, F. J. R. D. R., Piehl, F., Rottoli, M., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007600 · Cited by 296
Self-citationBril, V., Drużdż, A., Grosskreutz, J., Habib, A. A., Mantegazza, R., Sacconi, S., Utsugisawa, K., Vissing, J., Vu, T., Boehnlein, M., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00077-7 · Cited by 295
Howard, J. F., Bresch, S., Genge, A., Hewamadduma, C., Hinton, J., Hussain, Y., Juntas-Morales, R., Kaminski, H. J., Maniaol, A., Mantegazza, R., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00080-7 · Cited by 281
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
Muppidi, S., Utsugisawa, K., Benatar, M., Murai, H., Barohn, R. J., Illa, I., Jacob, S., Vissing, J., Burns, T. M., Kissel, J. T., et al. (2019) · Muscle & Nerve · doi:10.1002/mus.26447 · Cited by 262
Self-citation
Metadata
- Authors
- Muppidi, S., Wolfe, G. I., Conaway, M., Burns, T. M., & and the MG COMPOSITE AND MG‐QOL15 STUDY GROUP
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2011-10-17
- Volume
- 44
- Issue
- 5
- Pages
- 727-731
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W2102703420
- Cited by
- 173
- References
- 1
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.